Cover Image
Market Research Report

U.S. Direct-to-Consumer Genetic Testing Market Size By Test Type, By Technology, Industry Analysis Report, Application Potential, Competitive Market Share & Forecast, 2019 - 2025

Published by Global Market Insights Inc. Product code 913929
Published Content info 56 Pages
Delivery time: 2-3 business days
Price
Back to Top
U.S. Direct-to-Consumer Genetic Testing Market Size By Test Type, By Technology, Industry Analysis Report, Application Potential, Competitive Market Share & Forecast, 2019 - 2025
Published: September 24, 2019 Content info: 56 Pages
Description

Title:
U.S. Direct-to-Consumer Genetic Testing Market Size By Test Type (Carrier Testing, Predictive Testing, Ancestry & Relationship Testing, Nutrigenomics Testing), By Technology (Targeted Analysis, Single Nucleotide Polymorphism (SNP) Chips, Whole Genome Sequencing (WGS)), Industry Analysis Report, Application Potential, Competitive Market Share & Forecast, 2019 - 2025.

U.S. Direct-To-Consumer Genetic Testing Market is expected to exceed USD 850 million by 2025. Increasing public awareness pertaining to availability of DTC genetic testing kits will be a high impact rendering factor for the U.S. DTC genetic testing market growth.

Some major findings of the U.S. direct-to-consumer genetic testing market report include:

  • U.S. direct to consumer genetic testing industry is in developing stage and is yet to witness numerous growth opportunities with further advancements in technology.
  • Benefits associated with DTC genetic tests such as pre-diseases diagnosis that prevents hazardous repercussions has boosted their demand.
  • SNP chips is the fastest growing technology and is highly preferred since it provides accurate detection of defective genes in less time.
  • The U.S. DTC genetic testing industry is currently dominated by few industry players. Major players operating in the U.S. direct-to-consumer genetic testing market are Ancestry, Color Genomics, 23andMe, FamilytreeDNA (Gene by Gene), Easy DNA, Full Genome, Pathway Genomics and Genesis Healthcare among others. These companies manufacture technologically advanced genetic tests that renders them with competitive advantage.

Rising incidence of genetic diseases will accelerate demand for direct-to-consumer genetic testing kits over the forecast period. Genetic disorders such as achondroplasia, Parkinson's and Alzheimer's diseases are amongst the major ailments that cause adverse effect on an individual's life. Direct access to genetic tests allows patients to know the probability of acquiring such disorders that has reduced the mortality rates. As a result, DTC genetic testing kits have crucial role in recognizing the genetic alterations, thereby escalating its demand in coming years.

Growing demand for personalized DTC genetic testing services will be a high impact rendering factor for U.S. direct-to-consumer genetic testing market. DTC tests are user friendly and provide accurate results. Industry players focus on providing technologically advanced solutions that rises its adoption. For instance, 23andMe manufactures DTC test that utilizes genotype testing technology that provides data on health, carrier status, behavioral attributes for studying drug interactions. Therefore, growing availability of such advanced tests for detection of diseases will spur the industry growth. However, high cost of these kits may hamper the U.S. direct-to-consumer genetic testing market growth to some extent.

Predictive testing segment is anticipated to witness over 16% CAGR throughout the analysis timeframe. Increasing prevalence of genetic diseases will prove beneficial for the U.S. direct-to-genetic testing market growth. Predictive testing helps in detecting the disease before the onset of the disease that in turn will help in reducing the morbidity and mortality rate. Aforementioned factors will escalate the segment growth in near future.

Single nucleotide polymorphism (SNP) chips segment valued for more than USD 140 million in 2018 and it will grow substantially over the forecast period. SNP chips helps in analyzing gene sequences at a particular resolution that reveals detailed analysis regarding defective genes. SNP chips specifically detect changes at molecular level that further increases the efficiency of tests. Therefore, SNP technology is highly preferred during drug discovery process that should augment the segment growth.

Companies are investing in operational activities to offer reliable DTC tests to end-users. Moreover, they are also adopting numerous strategic initiatives such as acquisitions, mergers, product launches, geographical expansions and collaborations to acquire significant market share, sustain the competition and gain competitive advantage over others. For instance, in July 2018, 23andme announced collaboration with GlaxoSmithKline (GSK) company. Collaboration will enable the company to discover therapeutics to treat genetic diseases that enables company to expand its share in the DTC genetic testing market.

Table of Contents
Product Code: 4368

Table of Contents

Chapter 1. Methodology

  • 1.1. Methodology
  • 1.2. Market definition
  • 1.3. Forecast parameters
  • 1.4. Data sources
    • 1.4.1. Secondary
      • 1.4.1.1. Paid sources
      • 1.4.1.2. Unpaid sources
    • 1.4.2. Primary

Chapter 2. Executive Summary

  • 2.1. U.S. Direct-To-Consumer (DTC) genetic Testing industry 360 degree synopsis, 2014 - 2025

Chapter 3. U.S. Direct-To-Consumer (DTC) Genetic Testing Industry Insights

  • 3.1. Industry segmentation
  • 3.2. Industry landscape, 2014 - 2025
  • 3.3. Industry impact forces
    • 3.3.1. Growth drivers
      • 3.3.1.1. Rising public awareness regarding DTC genetic tests
      • 3.3.1.2. Increasing demand for personalized DTC genetic services
      • 3.3.1.3. Rising incidences of genetic disorders
    • 3.3.2. Industry pitfalls and challenges
      • 3.3.2.1. Defects in the DTC testing
  • 3.4. Growth potential analysis
    • 3.4.1. By test type
    • 3.4.2. By technology
  • 3.5. Regulatory landscape
  • 3.6. Porter's analysis
  • 3.7. Competitive landscape, 2018
    • 3.7.1. Strategy dashboard
  • 3.8. PESTEL analysis

Chapter 4. U.S. Direct-To-Consumer (DTC) Genetic Testing Market, By Test Type

  • 4.1. Key segment trends
    • 4.1.1. Market size, by country, 2014-2025 (USD Million)
    • 4.1.2. Market size, by country, 2014-2025 (000' Units)
  • 4.2. Carrier testing
    • 4.2.1. Market size, by country, 2014-2025 (USD Million)
    • 4.2.2. Market size, by country, 2014-2025 (000' Units)
  • 4.3. Predictive testing
    • 4.3.1. Market size, by country, 2014-2025 (USD Million)
    • 4.3.2. Market size, by country, 2014-2025 (000' Units)
  • 4.4. Ancestry & relationship testing
    • 4.4.1. Market size, by country, 2014-2025 (USD Million)
    • 4.4.2. Market size, by country, 2014-2025 (000' Units)
  • 4.5. Nutrigenomics testing
    • 4.5.1. Market size, by country, 2014-2025 (USD Million)
    • 4.5.2. Market size, by country, 2014-2025 (000' Units)
  • 4.6. Others
    • 4.6.1. Market size, by country, 2014-2025 (USD Million)
    • 4.6.2. Market size, by country, 2014-2025 (000' Units)

Chapter 5. U.S. Direct-To-Consumer (DTC) Genetic Testing Market, By Technology

  • 5.1. Key segment trends
  • 5.2. Targeted analysis
    • 5.2.1. Market size, by country, 2014-2025 (USD Million)
  • 5.3. Single nucleotide polymorphism (SNP) chips
    • 5.3.1. Market size, by country, 2014-2025 (USD Million)
  • 5.4. Whole genome sequencing [WGS]
    • 5.4.1. Market size, by country, 2014-2025 (USD Million)

Chapter 6. U.S. Direct-To-Consumer (DTC) Genetic Testing Market, By Country

  • 6.1. Key country trends
  • 6.2. U.S.
    • 6.2.1. Market size, by test type, 2014 - 2025 (USD Million)
    • 6.2.2. Market size, by test type, 2014-2025 (000' Units)
    • 6.2.3. Market size, by technology, 2014 - 2025 (USD Million)

Chapter 7. Company Profiles

  • 7.1. 23andMe, Inc.
    • 7.1.1. Business overview
    • 7.1.2. Financial data
    • 7.1.3. Product landscape
    • 7.1.4. Strategic outlook
    • 7.1.5. SWOT analysis
  • 7.2. Ancestry
    • 7.2.1. Business overview
    • 7.2.2. Financial data
    • 7.2.3. Product landscape
    • 7.2.4. Strategic outlook
    • 7.2.5. SWOT analysis
  • 7.3. Color Genomics
    • 7.3.1. Business overview
    • 7.3.2. Financial data
    • 7.3.3. Product landscape
    • 7.3.4. Strategic outlook
    • 7.3.5. SWOT analysis
  • 7.4. Easy DNA
    • 7.4.1. Business overview
    • 7.4.2. Product landscape
    • 7.4.3. Strategic outlook
    • 7.4.4. SWOT analysis
  • 7.5. FamilytreeDNA (Gene By Gene)
    • 7.5.1. Business overview
    • 7.5.2. Financial data
    • 7.5.3. Product landscape
    • 7.5.4. SWOT analysis
  • 7.6. Full Genome Corporation Inc.
    • 7.6.1. Business overview
    • 7.6.2. Financial data
    • 7.6.3. Product landscape
    • 7.6.4. SWOT analysis
  • 7.7. Helix OpCo LLC
    • 7.7.1. Business overview
    • 7.7.2. Financial data
    • 7.7.3. Product landscape
    • 7.7.4. Strategic outlook
    • 7.7.5. SWOT analysis
  • 7.8. Identigene, Inc.
    • 7.8.1. Business overview
    • 7.8.2. Product landscape
    • 7.8.3. SWOT analysis
  • 7.9. Karmagenes SA
    • 7.9.1. Business overview
    • 7.9.2. Financial data
    • 7.9.3. Product landscape
    • 7.9.4. SWOT analysis
  • 7.10. Living DNA Ltd.
    • 7.10.1. Business overview
    • 7.10.2. Product landscape
    • 7.10.3. Strategic outlook
    • 7.10.4. SWOT analysis
  • 7.11. MyHeritage Ltd.
    • 7.11.1. Business overview
    • 7.11.2. Financial data
    • 7.11.3. Product landscape
    • 7.11.4. Strategic outlook
    • 7.11.5. SWOT analysis
  • 7.12. Pathway genomics
    • 7.12.1. Business overview
    • 7.12.2. Financial data
    • 7.12.3. Product landscape
    • 7.12.4. Strategic outlook
    • 7.12.5. SWOT analysis

Data Tables

  • TABLE 1. U.S. Direct-To-Consumer (DTC) genetic testing industry 360 degree synopsis, 2014 - 2025
  • TABLE 2. Industry impact forces
  • TABLE 3. U.S. DTC genetic testing market, by test type, 2014 - 2025, (USD Million)
  • TABLE 4. U.S. DTC genetic testing market, by test type, 2014 - 2025, (000' Units)
  • TABLE 5. U.S. DTC genetic testing market, by technology, 2014 - 2025, (USD Million)

Charts & Figures

  • FIG. 1 Industry segmentation
  • FIG. 2 U.S. Direct-To-Consumer (DTC) genetic testing market, 2014 - 2025 (USD Million)
  • FIG. 3 Growth potential analysis, by test type
  • FIG. 4 Growth potential analysis, by technology
  • FIG. 5 Porter's analysis
  • FIG. 6 Strategy dashboard
  • FIG. 6 PESTEL analysis
Back to Top